Interferon α-2a suppositories in treating cervical erosion in 356 patients

彭慧霞,段钊,刘明,寸伟新
DOI: https://doi.org/10.3969/j.issn.1007-7669.2003.07.003
2003-01-01
Abstract:AIM: To observe the clinical effects of interferon α-2a for treatment of patients with cervical erosion. METHODS: Three hundred and sixty-five outpatients, with cervical erosion (age (32±s 11 a))were randomly divided into three groups (A,B,C). One hundred and forty patients in A group were treated with interferon α-2a suppositories, which were put into vagina, qod, total 9 suppositories as one therapy course, for two therapy courses. One hundred and twenty-two patients in B group were treated with thotothermal therapy. Ninty-four patients in C group were treated with interferon α-2a for two therapy courses after thotothermal therapy. The treatment outcomes were observed after three month, the relapse was observed after six month. RESULTS: The number of cuced patients in groups A,B,C were 116, 99, 82, respectively. The treatment outcomes of the three therapies showed no significant difference (P0.05). The number of relapse patients in A, B and C groups were 10, 15 and 7, respectively. No obvious difference was demonstrated (P0.05). The adverse reactions in A group were obviously more mild than those in the other two groups. CONCLUSION: Compared with thotothermal therapy and interferon plus thotothermal therapy, the interferon α-2a therapy in the treatment of cervical erosion has a similar effect, but with little adverse reaction and easy performation, thus, it can instead of thotothermal therapy.
What problem does this paper attempt to address?